“I’ve observed what I perceive to be a “market inefficiency” on the platform, which is what I want to call out today: Tier 1 VC bridge rounds.” This is the same lesson as Mark Suster’s 2014 gem Why Am I So […]
Beware of selection bias here, even when it’s not obvious (i.e. the last decade might be unique). “We analyzed over 2,600 seed-stage startup investments made on AngelList dating back to 2013 to determine the likelihood of any startup achieving unicorn […]
AngelList rounds up the “new batch of wellness-minded startups” tackling personalized health. Great to see NutriSense get a mention! | learn more
“If you miss the best-performing seed investment, you will eventually be outperformed by someone who blindly invests in every credible deal.” This data-driven analysis of investment returns paints a vivid picture. However, executing the strategy requires a good definition of credible […]